T2 Biosystems, Inc. (TTOO) - Medical Equipment - Deals and Alliances Profile

Date: October 29, 2014
Pages: 38
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: S5F24866F4EEN
Leaflet:

Download PDF Leaflet

T2 Biosystems, Inc. (TTOO) - Medical Equipment - Deals and Alliances Profile
Summary

T2 Biosystems, Inc. (T2 Biosystems) develops clinical diagnostic products. Its T2 Magnetic Resonance (T2MR) technology allows direct detection in complex samples, such as whole blood, plasma, serum, sputum and urine. T2 Biosystems offer T2MR instruments, including T2Candida, T2Bacteria and T2Hemostatis. The company’s T2MR detection technology is a biosensor technology, that provides rapid diagnostic results with minimal or no sample preparation. Its T2Candida product provides species-specific identification directly from whole blood and without the need for blood culture. The company also offers hemostasis measurements from unpurified clinical samples in hospitals, labs and physicians’ offices. T2 Biosystems is headquartered in Lexington, Massachusetts, the US.

T2 Biosystems, Inc. (TTOO) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements: The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy: The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company: Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.: The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company: Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research: Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
T2 Biosystems, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
T2 Biosystems, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014
T2 Biosystems, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014
T2 Biosystems, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014
T2 Biosystems, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014
T2 Biosystems, Inc., Medical Equipment, Deal Details
Venture Financing
T2 Biosystems Raises US$40 Million In Series E Financing
T2 Biosystems Secures US$23 Million In Series D Financing
T2 Biosystems Secures US$15 Million In Series C Round Of Financing
T2 Biosystems Secures US$10.8 Million In Series B Financing
Equity Offering
T2 Biosystems Raises USD65.7 Million in IPO
T2 Biosystems, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Recent Developments
Corporate Communications
Apr 03, 2014: T2 Biosystems Appoints Michael Pfaller, MD, Chief Medical Officer
Dec 11, 2013: T2 Biosystems Strengthens Management Team as Company Prepares for Launch of Flagship T2Candida Diagnostic Test
Jun 06, 2013: T2 Biosystems Appoints Marc Jones As CFO
Government and Public Interest
Jan 06, 2014: T2 Biosystems to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Dec 05, 2013: T2 Biosystems to Present at Oppenheimer’s 24th Annual Healthcare Conference
Product News
Sep 22, 2014: T2 Biosystems Receives FDA Authorization to Market T2Candida for the Detection of Sepsis-Causing Pathogens
Sep 22, 2014: T2 Biosystems Receives FDA Authorization to Market T2Dx for the Detection of Sepsis-Causing Pathogens
Jun 03, 2014: T2 Biosystems Submits 510(k) Application to the FDA for Review of T2Candida
Oct 17, 2013: T2 Biosystems Announces Publication of Data Demonstrating T2Candida Identifies Candida Significantly Faster than Current Methods
Sep 30, 2013: T2 Biosystems to Exhibit Rapid and Sensitive Assay for Sepsis Pathogens at IDWeek 2013
Sep 09, 2013: T2 Biosystems Announces direcT2 Pivotal Clinical Trial of T2Candida Enrolling at All Clinical Sites
Jul 01, 2013: T2 Biosystems Announces New Data Correlating T2HemoStat Results to Clinical Outcomes in Cardiovascular Disease at ISTH
Apr 24, 2013: T2 Biosystems Announces Publication Of Data Supporting Its T2Candida In Science Translational Medicine
Apr 16, 2013: T2 Biosystems Announces Advances In Novel Hemostasis Direct Detection Program For T2HemoStat
Apr 03, 2013: T2 Biosystems Receives US Patent Covering T2Candida Assay
Feb 05, 2013: T2 Biosystems Announces Patent Covering T2Hemostasis
Product Approvals
Sep 22, 2014: T2 Biosystems Receives FDA Authorization to Market T2Candida for the Detection of Sepsis-Causing Pathogens
Sep 22, 2014: T2 Biosystems Receives FDA Authorization to Market T2Dx for the Detection of Sepsis-Causing Pathogens
Clinical Trials
Sep 09, 2013: T2 Biosystems Announces direcT2 Pivotal Clinical Trial of T2Candida Enrolling at All Clinical Sites
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

T2 Biosystems, Inc., Medical Equipment, Key Facts, 2013
T2 Biosystems, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014
T2 Biosystems, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
T2 Biosystems, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014
T2 Biosystems, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014
T2 Biosystems, Inc., Deals By Market, 2008 to YTD 2014
T2 Biosystems, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014
T2 Biosystems Raises US$40 Million In Series E Financing
T2 Biosystems Secures US$23 Million In Series D Financing
T2 Biosystems Secures US$15 Million In Series C Round Of Financing
T2 Biosystems Secures US$10.8 Million In Series B Financing
T2 Biosystems Raises USD65.7 Million in IPO
T2 Biosystems, Inc., Key Competitors
T2 Biosystems, Inc., Key Employees

LIST OF FIGURES

T2 Biosystems, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014
T2 Biosystems, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
T2 Biosystems, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014
T2 Biosystems, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014
T2 Biosystems, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
T2 Biosystems, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014
T2 Biosystems, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014
T2 Biosystems, Inc., Medical Equipment, Deals by Market, 2008 to YTD 2014
Skip to top


Ask Your Question

T2 Biosystems, Inc. (TTOO) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: